Cargando…
Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics—Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer
Companion diagnostics (CDx) have become a major tool in molecular pathology and assist in therapy decisions in an increasing number of various cancers. Particularly, the developments in lung cancer have been most impressing in the last decade and consequently lung cancer mutation testing and molecul...
Autores principales: | Plönes, Till, Engel-Riedel, Walburga, Stoelben, Erich, Limmroth, Christina, Schildgen, Oliver, Schildgen, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810382/ https://www.ncbi.nlm.nih.gov/pubmed/26784235 http://dx.doi.org/10.3390/jpm6010003 |
Ejemplares similares
-
Absence of amplification of the FGFR1-gene in human malignant mesothelioma of the pleura: a pilot study
por: Plönes, Till, et al.
Publicado: (2014) -
Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch
por: Scheerens, H, et al.
Publicado: (2017) -
Companion diagnostics: changing patient management
Publicado: (2012) -
In situ Protein Detection for Companion Diagnostics
por: Gremel, Gabriela, et al.
Publicado: (2013) -
The current and future state of companion diagnostics
por: Agarwal, Amit, et al.
Publicado: (2015)